Products

Symbols

Huge freebie of custom symbols & auto-updating style guides

symbols.janlosert.com Design / Design Assets & Mockups

AI Benchmark
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Jan Losert
@janlosert· 8,944 followersCo-created with Nguyen Roman
Launched
9y ago
2017-01-25 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    The largest design kit for creating dashboards, now in React

    Aug 14, 2018 · 8y agoLaunch page

  • Launched on Product HuntLaunch

    Free Clonable UI Kit prepared fully in Webflow Designer

    May 2, 2018 · 8y agoLaunch page

  • Launched on Product HuntLaunch

    Huge freebie of custom symbols & auto-updating style guides

    Sep 27, 2017 · 9y agoLaunch page

  • Launched on Product HuntLaunch

    Master dashboard interface design with 100+ files

    Jan 25, 2017 · 9y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2012-04-02

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Website snapshots

Indexed 2017-09-27

Key pages

Desktop & mobile archive

Website snapshots pending capture.

Questions & evidence

How much website traffic does Symbols get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Symbols and what platforms does it support?
Symbols is catalogued under Design Assets & Mockups: Huge freebie of custom symbols & auto-updating style guides. Supported platforms: Web.

Related products in this category

Design / Design Assets & Mockups

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.